西亚试剂：Human Induced Pluripotent Stem Cells Free of Vector and Tra

发布时间：2025-10-17

Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

Junying Yu 1*, Kejin Hu 2, Kim Smuga-Otto 1, Shulan Tian 3, Ron Stewart 3, Igor I. Slukvin 4, James A. Thomson 5*

1 Morgridge Institute for Research, Madison, WI 53707–7365, USA.; Genome Center of Wisconsin, Madison, WI 53706–1580, USA.; Wisconsin National Primate Research Center, University of Wisconsin–Madison, Madison, WI 53715–1299, USA.
2 Wisconsin National Primate Research Center, University of Wisconsin–Madison, Madison, WI 53715–1299, USA.
3 Morgridge Institute for Research, Madison, WI 53707–7365, USA.; Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
4 Wisconsin National Primate Research Center, University of Wisconsin–Madison, Madison, WI 53715–1299, USA.; Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison, Madison, WI 53706, USA.
5 Morgridge Institute for Research, Madison, WI 53707–7365, USA.; Genome Center of Wisconsin, Madison, WI 53706–1580, USA.; Wisconsin National Primate Research Center, University of Wisconsin–Madison, Madison, WI 53715–1299, USA.; Department of Anatomy, University of Wisconsin–Madison, Madison, WI 53706–1509, USA.
* To whom correspondence should be addressed.

Reprogramming differentiated human cells to induced pluripotent stem (iPS) cells has applications in basic biology, drug development, and transplantation. Human iPS cell derivation previously required vectors that integrate into the genome, which can create mutations and limit the utility of the cells in both research and clinical applications. Here, we describe the derivation of human iPS cells using non-integrating episomal vectors. After removal of the episome, iPS cells completely free of vector and transgene sequences are derived that are similar to human embryonic stem (ES) cells in proliferative and developmental potential. These results demonstrate that reprogramming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors, and removes one obstacle to the clinical application of human iPS cells.

• 以上资料由西亚试剂：http://www.xiyashiji.com/ 提供此产品的详细信息如密度,含量,分子式,分子量等均可在西亚官网查询   
• 相关产品如汞乙酸汞氯化汞氧化汞碘化汞硫酸汞硝酸汞溴化汞硝酸亚汞氯化亚汞乙酸苯汞碘化汞钾硫氰酸汞氯化氨基汞三氯生三氯氧磷三氯乙烯水合氯醛三氯化磷三氯化钌三氯化钛三氯化铱三氯化铑三氯硫磷三氯乙烷三氯甲烷三氯卡班TCC1,3,5-三氯苯1,2,4-三氯苯1,2,3-三氯苯无水氯化铝三氯乙酸酐三氯乙酸钠碘甲烷二碘甲烷三碘甲烷 三氟碘甲烷硫酸二甲酯氯磺酸苯硫酚苯硫酚钠3-氨基苯硫酚2,6-二氯苯硫酚2,4-二氯苯硫酚2,5-二氯苯硫酚2-甲氧基苯硫酚2-氯乙醇 等均有销售.欢迎订购

 

上一篇：西亚试剂：睾丸移植：小鼠成精子“加工厂”
下一篇：西亚试剂：Parallel on-chip gene synthesis and application to optimiza